[1]
D. G. Kramer, “FAVIPIRAVIR AS A POTENTIAL DRUG IN THE TREATMENT OF COVID-19”, Int. J. Res. Granthaalayah, vol. 8, no. 4, pp. 7–12, Apr. 2020.